Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Feher
Attila Feher, Szeged HU
| Patent application number | Description | Published |
|---|---|---|
| 20080271200 | Plants Having Improved Growth Characteristics and Method for Making the Same - The present invention concerns a method for improving growth characteristics of plants by modulating expression of a nucleic acid sequence encoding a NAP1-like protein. The invention also relates to transgenic plants having improved growth characteristics, which plants have modulated expression of a nucleic acid encoding a NAP1-like protein. | 10-30-2008 |
| 20100162441 | Plants Having Improved Growth Characteristics And Method For Making The Same - The present invention concerns a method for improving growth characteristics of plants by modulating expression of a nucleic acid sequence encoding a NAP1-like protein. The invention also relates to transgenic plants having improved growth characteristics, which plants have modulated expression of a nucleic acid encoding a NAP1-like protein. | 06-24-2010 |
Gyula Feher, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090100098 | SYSTEM AND METHOD OF DISTRIBUTING MULTIMEDIA CONTENT - In accordance with one embodiment of the present invention, multimedia content may be streamed, together with associated timing information, to various users, who may provide feedback data in response to the multimedia content; the feedback data may be related to the multimedia content using the associated timing information, and then stored to some medium. | 04-16-2009 |
Janos Feher, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20110027348 | COMPOSITION AND METHOD INHIBITING INFLAMMATION - Composition and method for preventing, treating or attenuating inflammatory diseases by way of inhibiting lipid peroxidation and subsequent elementary inflammation through ensuring the presence of the following biologically active ingredients in the PMRS of cells involved in inflammation: i) at least one killed probiotic and ii) at least one omega 3 FA and iii) vitamin E and iv) ubiquinone by introducing a composition comprising any of the missing ingredients. | 02-03-2011 |
Janos Feher, Montopoli In Sabina IT
| Patent application number | Description | Published |
|---|---|---|
| 20100034795 | USE OF L-CARNITINE OR ALKANYL L-CARNITINE FOR THE PREPARATION OF A DIETARY SUPPLEMENT OR MEDICAMENT FOR THE TREATMENT OF CORNEAL DISEASE - Use of L-carnitine and/or one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of a dietary supplement or medicament for the treatment of corneal diseases is disclosed. | 02-11-2010 |
Liliana Feher, Szeged HU
| Patent application number | Description | Published |
|---|---|---|
| 20100184762 | PHTHALIMIDE DERIVATIVES THAT INFLUENCE CELLULAR VESICULAR SYSTEMS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF - The present invention relates to compounds that are suitable for treatment of disease states and influence cellular vesicular systems, especially the formation and/or function of lipid droplets, said compound having the general formula I (I) wherein X are each independently hydrogen, halogen, —C | 07-22-2010 |
Miklos Feher, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20100105900 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER - A CPT inhibitor compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof: or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject having cancer comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. | 04-29-2010 |
| 20110015174 | CYCLIC INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER - A CPT1 inhibitor compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof: or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject having cancer comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. | 01-20-2011 |
| 20110065702 | INDAZOLYL, BENZIMIDAZOLYL, BENZOTRIAZOLYL SUBSTITUTED INDOLINONE DERIVATIVES AS KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER - The present invention is directed to a compound is represented by Structural Formula (A):or a pharmaceutically acceptable salt therof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof. | 03-17-2011 |